Fox-Lewis Shivani, Muttaiyah Sharmini, Rahnama Fahimeh, McAuliffe Gary, Roberts Sally
Clinical Virology Registrar, Virology Department, LabPlus, Auckland City Hospital, Auckland.
Clinical Microbiologist, Microbiology Department, LabPlus, Auckland City Hospital, Auckland.
N Z Med J. 2020 Jul 31;133(1519):81-88.
The diagnostic sensitivity of the SARS-CoV-2 real time reverse transcription polymerase chain reaction (RT-PCR) test has not been determined. This has led to a degree of uncertainty in the interpretation of results, particularly in patients tested repeatedly. The aim of this study was to explore the characteristics of patients who initially tested negative, and subsequently tested positive for SARS-CoV-2.
This retrospective observational study utilised data from the LabPlus Virology laboratory, Auckland City Hospital, to identify cases (hospital and community) with initial negative and subsequent positive SARS-CoV-2 RT-PCR results. Their clinical and laboratory characteristics were summarised.
From 1 February to 13 April a total of 20,089 samples were received for SARS-CoV-2 testing. Of 2,011 samples from patients with multiple tests, 25 samples were positive. Nine samples were from patients who initially tested negative then tested positive. Reasons for the initial negative test results, which were all from upper respiratory tract samples, included pre-symptomatic presentation or late presentation. All patients had significant risk factors and ongoing or evolving symptoms, which warranted repeat testing.
Few patients had discordant test results for SARS-CoV-2 RT-PCR. For patients who have a significant risk factor and a negative test result, repeat testing should be performed.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)实时逆转录聚合酶链反应(RT-PCR)检测的诊断敏感性尚未确定。这导致在结果解读方面存在一定程度的不确定性,尤其是在多次检测的患者中。本研究的目的是探讨最初检测为阴性,随后检测为SARS-CoV-2阳性的患者的特征。
这项回顾性观察性研究利用奥克兰市医院LabPlus病毒学实验室的数据,确定最初SARS-CoV-2 RT-PCR结果为阴性,随后为阳性的病例(医院和社区)。总结了他们的临床和实验室特征。
从2月1日至4月13日,共收到20089份SARS-CoV-2检测样本。在多次检测患者的2011份样本中,25份呈阳性。9份样本来自最初检测为阴性,随后检测为阳性的患者。最初阴性检测结果均来自上呼吸道样本,原因包括症状前表现或延迟表现。所有患者都有显著的危险因素和持续或进展性症状,因此需要重复检测。
很少有患者的SARS-CoV-2 RT-PCR检测结果不一致。对于有显著危险因素且检测结果为阴性的患者,应进行重复检测。